Bone and Mineral Metabolism Disorders

Top Story

Rockwell receives FDA approval to begin manufacturing Calcitriol

July 17, 2018
In the JournalsPerspective

ESRD payment bundle linked to reductions in vitamin D prescriptions

June 15, 2018
Changes made in the Medicare payment methodology for dialysis care in 2011 that bundled prescription drugs and treatment payment resulted in both a drop in initiation…

FDA approves Lokelma for treatment of adults with hyperkalemia

May 21, 2018
The FDA recently announced approval of Lokelma, formerly ZS-9, for the treatment of hyperkalemia in adults. “We are pleased by today’s FDA approval of…

AstraZeneca receives approval in Europe for hyperkalemia drug

March 26, 2018
Two years after the FDA turned down an application for its hyperkalemia drug ZS-9, AstraZeneca announced on March 22 that it has received approval for the drug from the…
More Headlines »

Toward the Individualization of Treatment for Patients with Hyponatremia

This activity is supported by an educational grant from Otsuka America Pharmaceutical, Inc.

Hyponatremia is the most common electrolyte imbalance observed in patients, occurring in up to 30% of hospitalizations…
More »

Urinalysis Interpretation for Pediatricians

Pediatric Annals, March 2013, Volume 42 Issue 3
CME Educational Objectives 1. Cost-effectively evaluate microscopic hematuria and proteinuria. 2. Recognize important…
More »

Preventing Medical Errors for Clinical Health Professionals

No commercial support for this activity.

Discussing end of life issues and palliative care options with patients who have life-limiting illnesses is…
More »
Resource Centers
Transplant Centers Resource Center

Transplant Centers Resource Center